Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Kobayashi Pharmaceutical Statistics

Total Valuation

FRA:KOY has a market cap or net worth of EUR 2.20 billion. The enterprise value is 1.81 billion.

Market Cap	2.20B
Enterprise Value	1.81B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	74.34M
Shares Outstanding	n/a
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	18.42%
Owned by Institutions (%)	10.55%
Float	32.95M

Valuation Ratios

The trailing PE ratio is 31.61.

PE Ratio	31.61
Forward PE	n/a
PS Ratio	2.31
PB Ratio	1.79
P/TBV Ratio	1.96
P/FCF Ratio	37.25
P/OCF Ratio	18.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.55, with an EV/FCF ratio of 30.67.

EV / Earnings	26.03
EV / Sales	1.99
EV / EBITDA	10.55
EV / EBIT	14.62
EV / FCF	30.67

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.00.

Current Ratio	2.92
Quick Ratio	2.21
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.07
Interest Coverage	955.26

Financial Efficiency

Return on equity (ROE) is 5.65% and return on invested capital (ROIC) is 6.54%.

Return on Equity (ROE)	5.65%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	6.54%
Return on Capital Employed (ROCE)	10.26%
Revenue Per Employee	263,637
Profits Per Employee	19,262
Employee Count	3,615
Asset Turnover	0.62
Inventory Turnover	2.55

Taxes

In the past 12 months, FRA:KOY has paid 24.25 million in taxes.

Income Tax	24.25M
Effective Tax Rate	25.83%

Stock Price Statistics

The stock price has decreased by -13.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.69%
50-Day Moving Average	29.98
200-Day Moving Average	31.79
Relative Strength Index (RSI)	46.50
Average Volume (20 Days)	15

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:KOY had revenue of EUR 953.05 million and earned 69.63 million in profits. Earnings per share was 0.94.

Revenue	953.05M
Gross Profit	489.80M
Operating Income	129.67M
Pretax Income	93.89M
Net Income	69.63M
EBITDA	179.71M
EBIT	129.67M
Earnings Per Share (EPS)	0.94

Balance Sheet

The company has 411.21 million in cash and 4.42 million in debt, giving a net cash position of 406.79 million.

Cash & Cash Equivalents	411.21M
Total Debt	4.42M
Net Cash	406.79M
Net Cash Per Share	n/a
Equity (Book Value)	1.23B
Book Value Per Share	16.53
Working Capital	528.02M

Cash Flow

In the last 12 months, operating cash flow was 117.62 million and capital expenditures -58.53 million, giving a free cash flow of 59.10 million.

Operating Cash Flow	117.62M
Capital Expenditures	-58.53M
Free Cash Flow	59.10M
FCF Per Share	n/a

Margins

Gross margin is 51.39%, with operating and profit margins of 13.61% and 7.31%.

Gross Margin	51.39%
Operating Margin	13.61%
Pretax Margin	9.85%
Profit Margin	7.31%
EBITDA Margin	18.86%
EBIT Margin	13.61%
FCF Margin	6.20%

Dividends & Yields

This stock pays an annual dividend of 0.62, which amounts to a dividend yield of 2.16%.

Dividend Per Share	0.62
Dividend Yield	2.16%
Dividend Growth (YoY)	0.12%
Years of Dividend Growth	n/a
Payout Ratio	64.22%
Buyback Yield	0.83%
Shareholder Yield	3.00%
Earnings Yield	3.16%
FCF Yield	2.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 28, 2016. It was a forward split with a ratio of 2.

Last Split Date	Jun 28, 2016
Split Type	Forward
Split Ratio	2

Scores

FRA:KOY has an Altman Z-Score of 7.19 and a Piotroski F-Score of 5.

Altman Z-Score	7.19
Piotroski F-Score	5